loading

Biocryst Pharmaceuticals Inc Borsa (BCRX) Ultime notizie

pulisher
Aug 07, 2025

BioCryst Pharmaceuticals, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

Aug 07, 2025
pulisher
Aug 06, 2025

BioCryst Pharmaceuticals 2025 Q2 Earnings Record Net Income Surges 140% - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 06, 2025
pulisher
Aug 06, 2025

BioCryst Awards Massive Stock Package: 10 New Hires Get 126,450 Shares in Options and RSUs - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

BioCryst’s Earnings Call Highlights Strong Growth and Strategic Moves - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst targets $1B ORLADEYO peak and $700M cash by 2027 as leadership shifts and pipeline advances - MSN

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst’s Orladeyo: Strong Market Outlook and Strategic Expansion Drive Buy Rating - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst (BCRX) Q2 Revenue Jumps 50% - AOL.com

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst: Q2 Earnings Snapshot - New Haven Register

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst Pharmaceuticals Inc (BCRX) Q2 2025 Earnings Call Highlights: Record ORLADEYO Revenue ... - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

BioCryst Pharmaceuticals Reports Record Q2 2025 Results - TipRanks

Aug 05, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals: A Strategic Blueprint for $1 Billion in ORLADEYO Revenue by 2027 - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals' Q2 2025: Unpacking Contradictions in ORLADEYO Demand, Market Share, and Financial Metrics - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:BCRX) - Seeking Alpha

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level - Stocktwits

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals Soars 15.35% on Strong Earnings - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

Earnings call transcript: BioCryst Q2 2025 sees strong earnings beat, shares surge - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals Reports Impressive Q2 EarningsNews and Statistics - IndexBox

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Keeps Momentum With Strong ORLADEYO Sales And Rising Profits - Finimize

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharma soars 6.4% as Q2 results crush expectations - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Q2 2025 slides: ORLADEYO demand surges, profitability accelerates By Investing.com - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Pharmaceuticals: A High-Conviction Biotech Play with a Defensible Moat in Rare Disease Innovation - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Reports Strong Q2 2025 Financial Performance - TipRanks

Aug 04, 2025
pulisher
Aug 04, 2025

Is This the Dip to Buy in BioCryst Pharmaceuticals Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst (BCRX) Q2 Revenue Jumps 50% - The Motley Fool

Aug 04, 2025
pulisher
Aug 04, 2025

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 04, 2025
pulisher
Aug 03, 2025

Is it the right time to buy BioCryst Pharmaceuticals Inc. stockTrack high-yield stocks before they peak - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of BioCryst Pharmaceuticals Inc. stockDiscover undervalued stocks before they soar - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

BioCryst Pharmaceuticals Inc. Stock Analysis and ForecastTrack top-performing stocks effortlessly - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is BioCryst Pharmaceuticals Inc. company’s balance sheetCapitalize on emerging industry trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes BioCryst Pharmaceuticals Inc. stock price move sharplyMaximize gains with expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BioCryst Pharmaceuticals Inc. compare to its industry peersDiscover breakthrough stocks before the crowd - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is BioCryst Pharmaceuticals Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is BioCryst Pharmaceuticals Inc. stock expected to show significant growthStrong return on investment - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How volatile is BioCryst Pharmaceuticals Inc. stock compared to the marketBuild wealth steadily with smart stock selection - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive BioCryst Pharmaceuticals Inc. stock higher in 2025Unlock expert stock analysis and alerts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about BioCryst Pharmaceuticals Inc.Double or triple returns - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO - MSN

Aug 02, 2025
pulisher
Aug 02, 2025

Is BioCryst Pharmaceuticals Inc. a good long term investmentFree Stock Market Query - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is BioCryst Pharmaceuticals Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

BioCryst Pharmaceuticals Q2 2025 Earnings Preview: Revenue Expected to Rise 37% YoY - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

BioCryst Announces New President Amid Leadership Change - The Globe and Mail

Aug 01, 2025
pulisher
Jul 31, 2025

Healthcare Triangle, Inc. shares fall 3.23% after-hours as BioCryst Pharmaceuticals announces CEO transition. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst Pharmaceuticals' Leadership Transition: Strategic CEO Appointment and Its Impact on Pipeline Execution and Shareholder Value Creation - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst Pharmaceuticals Before Q2 Earnings: How To Play The Stock - Barchart.com

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock - The Globe and Mail

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst (BCRX) Announces Leadership Transition Plan - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Ch - GuruFocus

Jul 31, 2025
$26.62
price up icon 0.23%
$16.32
price down icon 1.12%
$9.435
price up icon 0.59%
drug_manufacturers_specialty_generic RDY
$13.69
price up icon 0.63%
$124.56
price down icon 0.90%
$302.24
price up icon 0.97%
Capitalizzazione:     |  Volume (24 ore):